The Analysis and Research Team at The Dental and Pharmaceutical Benefits Agency, TLV, is responsible for conducting comprehensive evaluations and data-driven research to inform the subsidization decisions for medicines, medical devices, and dental care treatments. This team analyzes the cost-effectiveness and societal impact of new and existing pharmaceutical products and dental procedures, ensuring that they meet the criteria for inclusion in the high-cost threshold. Additionally, the team contributes to policy formulation related to pricing, generic substitution, and the retail margin for pharmacies, ensuring accessibility and quality service within the pharmacy market.